The COVID-19 outbreak has accelerated the digitization of healthcare. Nascent projects in telemedicine have an important role in the mission to continue providing care whilst minimizing the risk of viral spread. But once a patient has seen their physician and been prescribed medication, the challenge remains of how to get that medication to the patient. […]

NEW YORK – Biotech company Bolt Biotherapeutics said last Thursday that it formally kicked off the Phase I trial of its investigational immunotherapy agent BDC-1001 in patients with HER2-expressing solid tumors […]

NEW YORK – Biocartis has expanded its current partnership with Seattle-based Immunexpress by launching a co-commercialization agreement for Immunexpress’ SeptiCyte Rapid test on Biocartis’ Idylla platform […]